Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report

To date, the molecular mechanisms that underline aggressiveness and resistance to tyrosine kinase inhibitors in some thyroid carcinomas (TCs) are not known yet. We report the case of a young patient with a metastatic poorly differentiated (PDTC) and follicular thyroid carcinoma (FTC) refractory to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Carla, Pogliaghi, Gabriele, Tosi, Delfina, Muzza, Marina, Bulfamante, Gaetano, Persani, Luca, Fugazzola, Laura, Cirello, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478947/
https://www.ncbi.nlm.nih.gov/pubmed/36119511
http://dx.doi.org/10.3389/fonc.2022.949098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478947/
https://www.ncbi.nlm.nih.gov/pubmed/36119511
http://dx.doi.org/10.3389/fonc.2022.949098

Ejemplares similares